BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11557626)

  • 21. Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte-macrophage colony stimulating factors in vitro.
    Lejeune M; Cantinieaux B; Harag S; Ferster A; Devalck C; Sariban E
    Br J Haematol; 1999 Sep; 106(3):756-61. PubMed ID: 10468870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema, and hypoxia.
    Hierholzer C; Kelly E; Lyons V; Roedling E; Davies P; Billiar TR; Tweardy DJ
    J Leukoc Biol; 1998 Feb; 63(2):169-74. PubMed ID: 9468275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of granulocyte colony-stimulating factor after liver transplantation.
    Foster PF; Mital D; Sankary HN; McChesney LP; Marcon J; Koukoulis G; Kociss K; Leurgans S; Whiting JF; Williams JW
    Transplantation; 1995 Jun; 59(11):1557-63. PubMed ID: 7539958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte colony-stimulating factor prevents ethanol-induced impairment in host defense in septic rats.
    Lang CH; Molina PE; Abumrad NN
    Alcohol Clin Exp Res; 1993 Dec; 17(6):1268-74. PubMed ID: 7509576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production.
    Shirai R; Kadota J; Tomono K; Ogawa K; Iida K; Kawakami K; Kohno S
    Clin Exp Immunol; 1997 Jul; 109(1):73-9. PubMed ID: 9218827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice.
    Deshmukh HS; Liu Y; Menkiti OR; Mei J; Dai N; O'Leary CE; Oliver PM; Kolls JK; Weiser JN; Worthen GS
    Nat Med; 2014 May; 20(5):524-30. PubMed ID: 24747744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor.
    O'Reilly M; Silver GM; Greenhalgh DG; Gamelli RL; Davis JH; Hebert JC
    J Trauma; 1992 Nov; 33(5):679-82. PubMed ID: 1281510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis.
    Alp E; Gozukucuk S; Canoz O; Kirmaci B; Doganay M
    BMC Infect Dis; 2004 Oct; 4():43. PubMed ID: 15491501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal timing of G-CSF administration after CD34+ immunoselected peripheral blood progenitor cell transplantation.
    Piccirillo N; Sica S; Laurenti L; Chiusolo P; La Barbera EO; SorĂ  F; Leone G
    Bone Marrow Transplant; 1999 Jun; 23(12):1245-50. PubMed ID: 10414910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats.
    Lundblad R; Wang MY; Kvalheim G; Lingaas E; Giercksky KE
    Shock; 1995 Jul; 4(1):68-73. PubMed ID: 7552781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs.
    Stephens KE; Ishizaka A; Wu ZH; Larrick JW; Raffin TA
    Am Rev Respir Dis; 1988 Nov; 138(5):1300-7. PubMed ID: 3059892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.
    Hustinx W; Benaissa-Trouw B; Van Kessel K; Kuenen J; Tavares L; Kraaijeveld K; Verhoef J; Hoepelman A
    Eur J Clin Invest; 1997 Dec; 27(12):1044-8. PubMed ID: 9466134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between tumor necrosis factor (TNF)-alpha and survival following granulocyte-colony stimulating factor (G-CSF) administration in burn sepsis.
    Arslan E; Yavuz M; Dalay C
    Burns; 2000 Sep; 26(6):521-4. PubMed ID: 10869822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of granulocyte colony-stimulating factor on hyperoxia-induced lung injury in newborn piglets.
    Wolkoff LI; Levine CR; Koo HC; LaGamma EF; Pollack S; Chester D; Bashore J; Davis JM
    Lung; 2002; 180(4):229-39. PubMed ID: 12391513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in the responses after administration of granulocyte colony-stimulating factor in septic patients with relative neutropenia.
    Ishikawa K; Tanaka H; Nakamori Y; Hosotsubo H; Ogura H; Nishino M; Shimazu T; Sugimoto H
    J Trauma; 2000 May; 48(5):814-24; discussion 824-5. PubMed ID: 10823524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease.
    Ina K; Kusugami K; Hosokawa T; Imada A; Shimizu T; Yamaguchi T; Ohsuga M; Kyokane K; Sakai T; Nishio Y; Yokoyama Y; Ando T
    J Gastroenterol Hepatol; 1999 Jan; 14(1):46-53. PubMed ID: 10029277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
    Heuft HG; Goudeva L; Blasczyk R
    Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis.
    Bauhofer A; Lorenz W; Kohlert F; Torossian A
    Crit Care Med; 2006 Mar; 34(3):778-84. PubMed ID: 16521271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.